Effects of small peptidic inhibitors of murine stem cells on human normal and malignant cells.
Guigon
M
M
Laboratoire d'Etudes de l'Hématopoièse, Faculté de Médecine St. Antoine, Paris, France.
Bonnet
D
D
Césaire
R
R
Lemoine
F
F
Najman
A
A
D000818:Animals; D002455:Cell Division / Q000187:drug effects*; D002460:Cell Line; D006131:Growth Inhibitors / Q000494:pharmacology*; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000187:drug effects; D006801:Humans; D007938:Leukemia; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood; D051379:Mice; D009000:Monocytes / Q000187:drug effects / Q000473:pathology; D009374:Neoplasms, Experimental; D009842:Oligopeptides / Q000494:pharmacology*; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives
D006131:Growth Inhibitors; D009842:Oligopeptides; C040758:hemoregulatory peptide 5b; C058504:goralatide; D011761:Pyrrolidonecarboxylic Acid